Evidence map›Paper›PMID 25598306›Full record

ArticleThe Journal of pediatrics2015

Adverse events following Haemophilus influenzae type b vaccines in the Vaccine Adverse Event Reporting System, 1990-2013.

Pedro L Moro, Christopher Jankosky, David Menschik, Paige Lewis, Jonathan Duffy, Brock Stewart, Tom T Shimabukuro

Abstract read
In one paragraph

Article in The Journal of pediatrics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Observational
  3. Article
  4. Adverse Events FollowingVaccines · 2025
    Article
  5. Article
  6. Neurological sequelae of vaccines.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023
    Review
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Pedro L MoroImmunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA. Electronic address: pmoro@cdc.gov.
Christopher JankoskyCenter for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
David MenschikCenter for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.
Paige LewisImmunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA.
Jonathan DuffyImmunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA.
Brock StewartImmunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA.
Tom T ShimabukuroImmunization Safety Office, Centers for Disease Control and Prevention, Atlanta, GA.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

objectiveTo characterize adverse events (AEs) after Haemophilus influenzae type b (Hib) vaccines reported to the US Vaccine Adverse Event Reporting System (VAERS), a spontaneous reporting surveillance system. STUDY

designWe searched VAERS for US reports after Hib vaccines among reports received from January 1, 1990, to December 1, 2013. We reviewed a random sample of reports and accompanying medical records for reports classified as serious. All reports of death were reviewed. Physicians assigned a primary clinical category to each reviewed report. We used empirical Bayesian data mining to identify AEs that were disproportionally reported after Hib vaccines.

resultsVAERS received 29,747 reports after Hib vaccines; 5179 (17%) were serious, including 896 reports of deaths. Median age was 6 months (range 0-1022 months). Sudden infant death syndrome was the stated cause of death in 384 (51%) of 749 death reports with autopsy/death certificate records. The most common nondeath serious AE categories were neurologic (80; 37%), other noninfectious (46; 22%) (comprising mainly constitutional signs and symptoms); and gastrointestinal (39; 18%) conditions. No new safety concerns were identified after clinical review of reports of AEs that exceeded the data mining statistical threshold.

conclusionReview of VAERS reports did not identify any new or unexpected safety concerns for Hib vaccines.

Indexed as

Adverse Drug Reaction Reporting SystemsBacterial CapsulesBayes TheoremChildChild, PreschoolFemaleFollow-Up StudiesHaemophilus InfectionsHaemophilus influenzae type bHaemophilus VaccinesHumansInfantInfant, NewbornMaleRetrospective StudiesRisk AssessmentHaemophilus influenzae type b polysaccharide vaccineHaemophilus Vaccines

Identifiers

PMID25598306
PMCPMC6500451

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.